These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38192006)

  • 1. Frailty model with change points for survival analysis.
    Kojima M; Orihara S
    Pharm Stat; 2024; 23(3):408-424. PubMed ID: 38192006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-parametric frailty Cox models for hierarchical time-to-event data.
    Gasperoni F; Ieva F; Paganoni AM; Jackson CH; Sharples L
    Biostatistics; 2020 Jul; 21(3):531-544. PubMed ID: 30590499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonproportional hazards and unobserved heterogeneity in clustered survival data: When can we tell the difference?
    Balan TA; Putter H
    Stat Med; 2019 Aug; 38(18):3405-3420. PubMed ID: 31050028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic frailty models based on compound birth-death processes.
    Putter H; van Houwelingen HC
    Biostatistics; 2015 Jul; 16(3):550-64. PubMed ID: 25681608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semiparametric estimation for nonparametric frailty models using nonparametric maximum likelihood approach.
    Chee CS; Do Ha I; Seo B; Lee Y
    Stat Methods Med Res; 2021 Nov; 30(11):2485-2502. PubMed ID: 34569366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of Under-Five Mortality in Rural Empowered Action Group States in India: An Application of Cox Frailty Model.
    Mani K; Dwivedi SN; Pandey RM
    Int J MCH AIDS; 2012; 1(1):60-72. PubMed ID: 27621959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A positive stable frailty model for clustered failure time data with covariate-dependent frailty.
    Liu D; Kalbfleisch JD; Schaubel DE
    Biometrics; 2011 Mar; 67(1):8-17. PubMed ID: 20528861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression analysis of arbitrarily censored survival data under the proportional odds model.
    Wang L; Wang L
    Stat Med; 2021 Jul; 40(16):3724-3739. PubMed ID: 33882618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual frailty excess hazard models in cancer epidemiology.
    Rubio FJ; Putter H; Belot A
    Stat Med; 2023 Mar; 42(7):1066-1081. PubMed ID: 36694108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential in infant, childhood and under-five death clustering among the empowered and non-empowered action group regions in India.
    Paul R; Rashmi R; Srivastava S
    BMC Public Health; 2021 Jul; 21(1):1436. PubMed ID: 34289824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-Cox model for non-proportional hazards survival analysis with frailty.
    Begun A; Kulinskaya E; Ncube N
    Stat Med; 2023 Aug; 42(18):3114-3127. PubMed ID: 37190904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation method of the semiparametric mixture cure gamma frailty model.
    Peng Y; Zhang J
    Stat Med; 2008 Nov; 27(25):5177-94. PubMed ID: 18613271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression standardization and attributable fraction estimation with between-within frailty models for clustered survival data.
    Dahlqwist E; Pawitan Y; Sjölander A
    Stat Methods Med Res; 2019 Feb; 28(2):462-485. PubMed ID: 28901198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bivariate joint frailty model with mixture framework for survival analysis of recurrent events with dependent censoring and cure fraction.
    Tawiah R; McLachlan GJ; Ng SK
    Biometrics; 2020 Sep; 76(3):753-766. PubMed ID: 31863594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of statistical methods for the analysis of recurrent adverse events in the presence of non-proportional hazards and unobserved heterogeneity: a simulation study.
    Patson N; Mukaka M; Kazembe L; Eijkemans MJC; Mathanga D; Laufer MK; Chirwa T
    BMC Med Res Methodol; 2022 Jan; 22(1):24. PubMed ID: 35057743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using frailties in the accelerated failure time model.
    Pan W
    Lifetime Data Anal; 2001 Mar; 7(1):55-64. PubMed ID: 11280848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A frailty model approach for regression analysis of multivariate current status data.
    Chen MH; Tong X; Sun J
    Stat Med; 2009 Nov; 28(27):3424-36. PubMed ID: 19739240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximum penalized likelihood estimation in a gamma-frailty model.
    Rondeau V; Commenges D; Joly P
    Lifetime Data Anal; 2003 Jun; 9(2):139-53. PubMed ID: 12735493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational issues in fitting joint frailty models for recurrent events with an associated terminal event.
    Toenges G; Jahn-Eimermacher A
    Comput Methods Programs Biomed; 2020 May; 188():105259. PubMed ID: 31862679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.